InvestorsHub Logo
Followers 82
Posts 6802
Boards Moderated 0
Alias Born 02/03/2018

Re: ae kusterer post# 570660

Friday, 02/24/2023 9:42:51 AM

Friday, February 24, 2023 9:42:51 AM

Post# of 699034
In case this was missed: Linda Lau comments to regulations.gov:
"So, a part of it is having the FDA think a little bit differently about what constitutes approval. On the converse, like the Optune device, that Novocure device, is FDA-approved. But I must say a lot of patients are like, "Well, I don't really like it." And I think on the physician side, we just don't understand how it works and there are a lot of problems with the clinical trial design.

There was no true placebo arm, but they did design it in a way that met the FDA checkboxes. So, it was approved, but a lot of us don't really believe that it works. I think it's one of these things where if your ultimate goal is to cure GBM, it's hard to reconcile all these different factors; the regulatory factors, the financial factors, as well as the science and the biology of the tumor itself, which is very complex."

Where are the shills crying out "foul?"

ILT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News